ArticleFrontiers in pharmacology2021

Leonurine-Repressed miR-18a-5p/SOCS5/JAK2/STAT3 Axis Activity Disrupts CML malignancy.

Hui-Min Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.